Demodex Blepharitis
Advertisement
Mr. Dermott Ryan, a patient with Demodex blepharitis, provides firsthand insight on the impact of the disease.
Eye care experts provide a physician-focused perspective on the current treatment paradigm for Demodex blepharitis.
A panel of experts discusses lotilaner ophthalmic solution 0.25%, the first FDA-approved treatment for Demodex blepharitis.
An ophthalmology panel explains the pros and cons of the current standard of care for treating Demodex blepharitis.
A panel of experts discusses how Demodex blepharitis presents and what treatment options are typically used.
A panel provides a breakdown on Demodex blepharitis, a prevalent ocular disease caused by an infestation of Demodex mites.
Advertisement
630 Madison Ave.
Manalapan, NJ 07726
© 2024 Mashup Media, LLC. All rights reserved.